Company profile for Porton Advanced Solutions

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Porton Advanced Solutions (Porton Advanced) is a Cell and Gene Therapy (CGT) CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability a...
Porton Advanced Solutions (Porton Advanced) is a Cell and Gene Therapy (CGT) CDMO. We provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clients’ therapeutic product needs at pre-clinical, clinical, and commercial stages.Our dedicated process and analytical development teams have established robust platform-based USP/DSP and GMP manufacturing capability and capacity, as well as proprietary technologies to further empower our clients’ successes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6 Cedarbrook Dr Cranbury Township NJ 08512
Telephone
Telephone
+86 0512 88850385
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/porton-advanced-and-eva-pharma-sign-mou-to-expand-car-t-cell-therapy-access-in-the-middle-east-and-africa-302491979.html

PR NEWSWIRE
26 Jun 2025

https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-tongeye-to-accelerate-development-of-ipsc-rpec-transplantation-therapy-302462976.html

PR NEWSWIRE
22 May 2025

https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-hualong-biological-to-accelerate-matc-cell-therapy-development-for-solid-tumor-treatment-breakthroughs-302458929.html

PR NEWSWIRE
19 May 2025

https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-eureka-therapeutics-to-accelerate-tcell-therapy-development-302405703.html

PR NEWSWIRE
19 Mar 2025

https://www.prnewswire.com/news-releases/porton-advanced-and-geneseed-biotech-enter-into-strategic-collaboration-to-focus-on-advancing-circrna-innovative-therapeutics-302209884.html

PR NEWSWIRE
30 Jul 2024

https://www.prnewswire.com/news-releases/porton-advanced-introduces-the-maxcyte-expert-gtx-flow-electroporation-instrument-continuing-to-provide-customers-with-end-to-end-cell-and-gene-therapy-cro--cdmo-services-302180310.html

PR NEWSWIRE
25 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty